MetaCap

Who Owns Cytek Biosciences Stock?

NASDAQ: CTKBIndustrialsBiotechnology: Laboratory Analytical InstrumentsUSD

6.12-0.20 (-3.16%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Ownership breakdown

Held by institutions
63.67%
Institutional holders
209
  • Institutions 63.7%
  • Insiders 8.7%
  • Public and other 27.6%

Who owns Cytek Biosciences stock?

Institutional investors own about 63.7% of Cytek Biosciences's shares, spread across 209 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 8.68% of CTKB.

The largest institutional holders are Blackrock Inc. (9.32%), Millennium Management Llc (7.14%) and HHLR Advisors, LTD (5.09%). Together, the top 10 institutions control 43.4% of shares outstanding. In their latest filings, 4 of the top 10 institutions increased their CTKB positions and 5 reduced them.

Summary generated from market data by MetaCap's automated system. Methodology

Top institutional holders of CTKB

Cytek Biosciences top institutional holders
InstitutionShares% HeldChange
Blackrock Inc.12.19M9.32%+27.2%
Millennium Management Llc9.34M7.14%+48.4%
HHLR Advisors, LTD6.66M5.09%0.0%
Boston Partners6.53M4.99%-14.8%
Topline Capital Management, LLC6.28M4.80%-11.1%
Vanguard Capital Management LLC4.89M3.74%-1.1%
Geode Capital Management, LLC3.07M2.34%+0.2%
Acadian Asset Management. LLC2.72M2.08%+97.6%
Dimensional Fund Advisors LP2.57M1.96%-1.9%
State Street Corporation2.55M1.95%-0.5%

% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.

Top mutual fund and ETF holders of CTKB

Cytek Biosciences top fund holders
FundShares% Held
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund3.53M2.70%
iShares Trust-iShares Russell 2000 ETF3.18M2.43%
Trust for Professional Managers-Column Small Cap Select Fund2.58M1.98%
Fidelity Salem Street Trust-Fidelity Small Cap Index Fund1.35M1.03%
ROYCE MICRO-CAP TRUST, INC.-Royce Micro-Cap Trust Inc1.32M1.01%
VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund1.30M0.99%
iShares Trust-iShares Russell 2000 Value ETF1.15M0.88%
RBB Fund, Inc.-WPG Partners Select Small Cap Value Fund1.12M0.86%
iShares Trust-iShares Biotechnology ETF944.42K0.72%
VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund696.71K0.53%

Frequently asked questions

Who is the largest shareholder of Cytek Biosciences?

Blackrock Inc. is the largest institutional shareholder of CTKB, owning 9.32% of shares outstanding (12.19M shares) as of its latest 13F filing.

What percentage of Cytek Biosciences is owned by institutions?

Institutions own about 63.7% of CTKB shares and 69.7% of the public float.

How much of Cytek Biosciences do insiders own?

Insiders, such as officers and directors, own about 8.68% of CTKB shares outstanding.

Where does institutional ownership data come from?

Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.

Related